skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV

Original Research

(1181) Views  (493) Full article downloads

Authors: Suad Kapetanovic, Lisa Aaron, Paige L Williams, et al

Published Date August 2010 Volume 2010:2 Pages 39 - 48
DOI: http://dx.doi.org/10.2147/NBHIV.S12517

Suad Kapetanovic1, Lisa Aaron2, Paige L Williams2, John Farley3, Patricia A Sirois4, Patricia A Garvie5, Deborah A Pearson6, James M Oleske7, Grace Montepiedra2, for the IMPAACT/PACTG 219C Team

1University of Southern California/Keck School of Medicine, Los Angeles, California, USA; 2Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA; 3University of Maryland School of Medicine, Baltimore, Maryland, USA; 4Tulane University School of Medicine, New Orleans, Louisiana, USA; 5St Jude Children’s Research Hospital, Memphis, TN, USA; 6University of Texas Medical School at Houston, Houston, Texas, USA; 7UMDNJ New Jersey Medical School, Newark, New Jersey, USA

Purpose: Perinatally HIV-infected children, who are increasingly aging into adolescence and early adulthood, have significant rates of psychiatric co-morbidities, some of which are treated with second-generation antipsychotics (SGAs). SGAs have been associated with elevated total cholesterol (TC) in youth, but no studies have examined this association in perinatally HIV-infected youth. This study examined changes in TC levels of youth with perinatally acquired HIV infection and co-morbid psychiatric conditions treated with SGAs.

Patients and methods: Long-term changes in TC levels were examined using data from the US multisite prospective Pediatric AIDS Clinical Trials Group 219C cohort study. The change in TC levels from baseline to 12 months after initiating SGA use was compared between 52 SGA-exposed and 148 matched SGA-unexposed perinatally HIV-infected youth, using generalized estimating equation models adjusting for other covariates. The prevalence and time to incident hypercholesterolemia were also compared between these 2 groups.

Results: After adjustment for confounders, 52 youth with prescriptions for SGAs had a larger increase in TC levels than 148 matched youth without antipsychotic prescriptions (mean ­difference = 9 mg/dL, z = 1.96, df = 1, P = 0.0496). Among youth with TC below 220 mg/dL at baseline, 27% of SGA-exposed youth developed hypercholesterolemia (defined as two consecutive TC measurements ≥220 mg/dL), compared with 13% of SGA-unexposed patients (Fisher’s exact test, P = 0.046).

Conclusions: Caution should be used in prescribing SGAs to perinatally HIV-infected youth with psychiatric co-morbidities due to increased risk of hypercholesterolemia. Patients should be monitored, and alternative evidence-based treatments considered when available.

Keywords: HIV-infected youth with psychiatric co-morbidities, second-generation antipsychotics in youth, cholesterol in youth







Readers of this article also read:

Periosteoplasty for covering gingival recessions: Clinical results
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Erratum